Delivery Order SPE2DB20D3101-SPE2DB25FRUF7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Methotrexate 2.5 mg tablets in quantities of 100 units, with a ceiling value of $2,119.10. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 15,...
- The Defense Logistics Agency awarded a delivery order valued at $4,402.77 to AmerisourceBergen Drug Corp for the supply of Methotrexate 2.5 mg tablets in unit dose packaging of 20s. This firm fixed price delivery order, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a non-set-aside competitive award executed under AmerisourceBergen's existing pharmaceutical supply contract vehicle. The product will be delivered to the company's corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methotrexate 2.5 mg tablets in quantities of 100 units, with a ceiling value of $15,845.94. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 3, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The award represents a...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $739 to Amerisourcebergen Drug Corporation for the supply of 100 tablets of 2.5 mg methotrexate. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The period of performance is September 21-22, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for a common drug supports the Agency's mission to provide critical...
- The Defense Logistics Agency awarded a $373,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 100 units of 2.5 mg methotrexate tablets. As one of the largest pharmaceutical distributors supporting the Department of Defense supply chain, Amerisourcebergen will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania by July 20, 2023 to fulfill DLA requirements. The delivery order was issued under an existing DLA-wide supply...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,567,678,591 units of Methotrexate 2.5 mg tablets in 100-count bottles. The contract has a ceiling value of $21,076.61 and runs through March 25, 2025. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite...
- The Defense Logistics Agency Troop Support Medical awarded a $29,840 delivery order to Amerisourcebergen Drug Corporation for 100 tablets of 2.5 mg methotrexate. The delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle and calls for Amerisourcebergen to provide the pharmaceutical products from its facility in Conshohocken, Pennsylvania, with delivery required between July 14-17, 2023. The pricing is firm fixed price. No subcontractors or set-aside...
- The Defense Logistics Agency Troop Support Medical awarded a $132,100 delivery order to Amerisourcebergen Drug Corporation for 100 tablets of 2.5 mg methotrexate. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle and calls for the pharmaceutical products to be delivered to a facility in Conshohocken, Pennsylvania by September 19, 2023. Amerisourcebergen will serve as the prime contractor to supply the requested prescription drugs to the Defense...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 2.5 mg methotrexate tablets in 100-count packages, with a ceiling value of $1,240.16 and a period of performance through July 2, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,951.56 Firm Fixed Price Delivery Order covers the supply of 4,565,087,756 units of Methotrexate 2.5 mg Tablets in 100-count bottles, with a completion date of July 9, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which serves as the primary vehicle...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRUF7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Methotrexate 2.5 mg tablets in quantities of 100 units, with a ceiling value of $1,188.90. This is a firm fixed-price delivery order with an ultimate completion date of September 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this competitive award, reflecting the company's established capability to meet federal pharmaceutical procurement requirements through open competition. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor headquartered in Pennsylvania that serves as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through the DLA's Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/3/25 |